Pharmasset is a Winner

Jul 25, 2011
J. Webster
Comments Off on Pharmasset is a Winner

On March 20, 2009, Pharmasset, Inc, with the very apt ticker of VRUS, was a 7.80 stock. Since then, about two years later, it’s a $135 stock. Talk about a nice run up. That’s like over a 1000% gain.

What’s more though, the stock’s run might not be done. Morgan Stanley recently raised its price target for Pharmasset to over $200 a share. I guess this is a stock that you should have bought and held, hopefully you did. I doubt it though. That takes a lot of discipline.

What does Pharmasset do? Simple: Pharmasset, Inc. is a clinical-stage pharmaceutical company focused on discovering, developing, and commercializing novel drugs to treat viral infections.

Related Posts Plugin for WordPress, Blogger...

Comments are closed.